Earnings
Home›Earnings›Previews›GE HealthCare tops Q2 expectations, reaffirming 2026 o…
GE HealthCare tops Q2 expectations, reaffirming 2026 outlook
The company expects Q2 revenue of $5.295 billion, with preliminary organic growth accelerating to 3.5% year over year.
GE HealthCare Technologies Inc. reported preliminary fiscal second-quarter 2026 results that beat management expectations, citing accelerated top-line growth and earnings. The quarter ended June 30, 2026, with the company projecting total revenue of $5.295 billion, up 5.7% year over year from $5.007 billion in Q2 2025.
GE HealthCare said organic revenue growth was 3.5% year over year, after adjusting for $62 million from acquisitions and a $51 million foreign currency tailwind. It also noted that the 3.5% organic pace represents an acceleration from Q1's 2.9% rate.
The company reaffirmed its full-year 2026 outlook, including organic revenue growth of 3% to 4%, Adjusted EPS of $4.80 to $5.00, and an Adjusted EBIT margin between 15.4% and 15.7%. Management attributed margin resilience to operational steps such as localizing supply chains and multi-sourcing to help neutralize supply chain inflation and tariff impacts that previously weighed on margins.
GE HealthCare also announced CFO changes: Chief Financial Officer James Saccaro will step down on August 14 to take an expanded role outside the medical technology industry. George Newcomb, the company’s controller and chief accounting officer, will serve as interim CFO while GE HealthCare searches for a permanent successor.